New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
04:55 EDTCGIX, CGIX, CGIX, HART, HART, HART, NURO, NURO, NURO, CANF, CANF, CANF, AMBS, AMBS, AMBS, AGEN, AGEN, AGEN, AVXL, AVXL, AVXL, SYN, SYN, SYN, CEMI, CEMI, CEMI, SRNE, SRNE, SRNE, OXBT, OXBT, OXBTOneMedPlace to hold a forum
7th Annual OneMedForum SF 2014 is being held in San Francisco on January 13-15.
News For CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT From The Last 14 Days
Check below for free stories on CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
08:47 EDTSRNESorrento Therapeutics receives funding for development of Myc inhibitor
Subscribe for More Information
07:47 EDTCGIXCancer Genetics to acquire Gentris
Subscribe for More Information
July 16, 2014
07:23 EDTCGIXRedChip Companies to hold a virtual conference
Subscribe for More Information
July 14, 2014
18:15 EDTNUROOn The Fly: After Hours Movers
Subscribe for More Information
17:16 EDTNURONeuroMetrix files to sell 5.89M shares of common stock for holders
Subscribe for More Information
07:23 EDTAMBSAlzheimer's Association to hold a conference
Subscribe for More Information
July 10, 2014
10:29 EDTCANFCan-Fite BioPharma partnering potential to expand, says Roth Capital
Subscribe for More Information
10:27 EDTCANFCan-Fite CF102 approved for compassionate use in Israel
Can-Fite BioPharma announced that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program. The program allows doctor-initiated single-patient access to investigational treatments for innovative or investigational products not yet registered in any country worldwide. Can-Fite has also previously received Orphan Drug Designation from the U.S. FDA for CF102 in the treatment of advanced hepatocellular carcinoma.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use